News
Actemra Approved for Treatment of Hospitalized COVID-19 Patients
Actemra (tocilizumab) is an interleukin-6 receptor antagonist.
Lower average oxygen delivery rates seen in association with Asian, Black, Hispanic versus White race, ethnicity